Outside Review of Clinical Data Finds a Spinal Treatment’s Benefit Overstated
Tuesday, June 18, 2013 - 00:50
in Health & Medicine
Independent reviews of clinical trial data concluded that Infuse, a bioengineered bone product, was not significantly better than a traditional bone graft, and that it might pose risks.